# The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial

> **NCT06871111** · PHASE1 · RECRUITING · sponsor: **University of Chicago** · enrollment: 24 (estimated)

## Conditions studied

- Liver Diseases
- Liver Failure
- Cirrhosis, Liver

## Interventions

- **BIOLOGICAL:** Commensal Bacteria Strains

## Key facts

- **NCT ID:** NCT06871111
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2027-08-04
- **Final completion:** 2028-02-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06871111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06871111, "The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06871111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*